The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

The president of the American Society of Nuclear Cardiology said there are no shortfalls reported at this time, but the organization is keeping an eye on the situation as more countries implement travel bans.

Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.

An analysis of PARTNER 2 data published in the New England Journal of Medicine Jan. 29 suggests five-year post-op outcomes are similar among heart patients who undergo either transcatheter or surgical aortic valve replacement.

The American Society of Echocardiography released the new recommendations to replace its 2007 edition.

A number of female cardiologists are leading, or preparing to lead, top cardiology organizations this year. Could 2020 mean a paradigm shift for the field?

The 47-page document, published Jan. 6 in the Journal of the American College of Cardiology, touches on multiple cardiac imaging modalities, rating them based on their appropriateness for examining adults and children with previously diagnosed heart defects.